Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Mol Sci ; 23(18)2022 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-36142384

RESUMO

Telomere shortening is the main molecular mechanism of aging, but not the only one. The adaptive immune system also ages, and older organisms tend to develop a chronic pro-inflammatory status with low-grade inflammation characterized by chronic activation of the innate immune system, called inflammaging. One of the main stimuli that fuels inflammaging is a high nutrient intake, triggering a metabolic inflammation process called metainflammation. In this study, we report the anti-inflammatory activity of several senolytic drugs in the context of chronic inflammation, by using two different zebrafish models: (i) a chronic skin inflammation model with a hypomorphic mutation in spint1a, the gene encoding the serine protease inhibitor, kunitz-type, 1a (also known as hai1a) and (ii) a non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH) model with inflammation induced by a high-fat diet. Our results show that, although these models do not manifest premature aging, the senolytic drugs dasatinib, navitoclax, and venetoclax have an anti-inflammatory effect that results in the amelioration of chronic inflammation.


Assuntos
Hepatopatia Gordurosa não Alcoólica , Peixe-Zebra , Compostos de Anilina , Animais , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios/uso terapêutico , Compostos Bicíclicos Heterocíclicos com Pontes , Senescência Celular , Dasatinibe/farmacologia , Dasatinibe/uso terapêutico , Inflamação/tratamento farmacológico , Senoterapia , Inibidores de Serina Proteinase/farmacologia , Sulfonamidas
2.
Expert Opin Drug Discov ; 18(8): 903-915, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36383405

RESUMO

INTRODUCTION: The combination of Virtual Screening (VS) techniques with in vivo screening in the zebrafish model is currently being used in tandem for drug development in a faster and more efficient way. AREAS COVERED: We review the different virtual screening techniques, the use of zebrafish as a vertebrate model for drug discovery and the synergy that exists between them. EXPERT OPINION: We highlight the advantages of combining virtual and zebrafish larvae screening for drug discovery. On the one hand, VS is a faster and cheaper tool for searching active compounds and possible candidates for therapy than in vivo screening when processing large compound libraries. On the other hand, zebrafish larvae form a vertebrate model that allows in vivo screening of large amounts of the compounds. Importantly, physiology and chemical response are mostly conserved between zebrafish and mammals. The availability of the transgenic and mutant zebrafish lines allows an analysis of a specific phenotype upon treatment, along with toxicity, off-target effect, side effects, and dosage. The advantages of VS, in vivo whole animal approach screening, and the screening combinations are also reviewed.


Assuntos
Ensaios de Triagem em Larga Escala , Peixe-Zebra , Animais , Ensaios de Triagem em Larga Escala/métodos , Descoberta de Drogas/métodos , Animais Geneticamente Modificados , Fenótipo , Avaliação Pré-Clínica de Medicamentos/métodos , Mamíferos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA